You are viewing the site in preview mode

Skip to main content

Advertisement

Fig. 4 | BMC Infectious Diseases

Fig. 4

From: Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom

Fig. 4

Deterministic sensitivity analyses (a) Canada (b) UK. Note: The grey vertical line corresponds to all the uncertain parameters being at their respective base values. The red segments of the bars correspond to result values increasing the base case ICUR and the blue segments of the bars correspond to result values decreasing the base case ICUR; Figure presented for the UK is based on Scenario UK1, UK2 is very similar (data not shown); ER, emergency room; GP, general practitioner, QIV, quadrivalent influenza vaccine; QALY, quality-adjusted life-year

Back to article page